Results 91 to 100 of about 178,280 (162)

Acetylcholine receptor antibody in the diagnosis of myasthenia gravis

, 1983
The acetylcholine receptor (AchR) antibody assay has a key role in the diagnosis of myasthenia gravis. In this article, the role of AchR antibody assay in the diagnosis of ocular and generalized myasthenia gravis is reviewed, and compared to standard ...
Nicholson, G. A., Griffiths, Lyn R., McLeod, J. G.   +2 more
core  

Myasthenia gravis in children

Magyar nyelvre súlyos izomgyengeségként fordítható myasthenia gravis görög (myasthenia = izomgyengeség) és latin (gravis = súlyos) szavakból tevődik össze, és egy ritka, krónikus neurológiai betegséget jelöl, ami a vázizmok fáradékonyságával és ...
Mostafa, Mousa
core  

Intravenous Methylprednisolone Treatment of Ocular Myasthenia Gravis

, 2006
Ocular myasthenia gravis is a chronic disease generally requiring years of treatment. Treatment consists of either Mestinon or immunosuppressive agents. Many patients with ocular myasthenia gravis are elderly and long term prednisone treatment is fraught
K. Warden; I. Ben-Bassat Mizrachi; W. Cornblath
core  

Ocular Myasthenia Gravis: AChR Seropositivy and Generalization

, 2020
Ocular Myasthenia Gravis (OMG) is an autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of extraocular muscles, levator palpebrae, and orbicularis oculi resulting in fatigable ptosis and binocular diplopia.
Mariana de Virgiliis; Luciana Iacono; Maria Laura Braccia Gancedo; Pablo Perez Vega; Luciana Lagos; Haydee Martinez; Lidia Sarotto; Marcela Dulce; Dolores Ribero Ayerza; Glenda Dibner; Mariana Ingolotti
core  

Case Report - Ocular myasthenia gravis coincident with thyroid ophthalmopathy

, 2003
Graves' disease and myasthenia gravis are both auto-immune diseases and the coexistence of these two diseases is well recognized. Myasthenia gravis is more frequent in patients with thyroid disease.
A. Yaman, H. Yaman
core   +2 more sources

Ocular Myasthenia Gravis with Multiple Episodes of Spontaneously Remitting Symptoms

, 2006
Myasthenia gravis is a chronic disease generally requiring lifelong treatment. Approximately 20% of patients with myasthenia gravis will have a spontaneous transitory or complete clinical remission during the course of their disease. Although a relapsing
K. Warden; W. Cornblath
core  

Add‐On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real‐World Case Series

Brain and Behavior
Introduction Refractory ocular myasthenia gravis (MG) represents a significant therapeutic challenge, as conventional immunotherapies often prove ineffective.
Jing Lin, Yue Li, Mengcui Gui, Bitao Bu, Zhijun Li   +4 more
doaj   +1 more source

Characteristics of Diagnostic Testing in Ocular Myasthenia Gravis

, 2014
Estimates of the sensitivity of diagnostic testing in ocular myasthenia gravis vary.
Crandall E. Peeler; Lina Nagia; Jaao Lemos; Christopher Glisson; Sunita Yedavally; David Kaufman; Eric Eggenberger; Wayne T. Cornblath
core  

Retrospective analysis of ocular myasthenia gravis patients in Kuwait

, 2012
The statistics of ocular myasthenia gravis is fairly well established in western literature. This study was aimed to examine the rates of conversion of ocular myasthenia to generalized myasthenia in Kuwait and their response to ...
Raed Behbehani; Ashref AlMoosa
core  

A Case Report of Juvenile Myasthenia Gravis; Misdiagnosis and Considerations

Clinical Case Reports
Juvenile myasthenia gravis (JMG) is a rare autoimmune disease acquired in childhood, comprising 8%–15% of all myasthenia gravis cases depending on geographic and ethnic populations.
Elaheh Heidari, Amin Saeidinia
doaj   +1 more source